(Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations,...
By Maggie FickLONDON (Reuters) - Intermittent shortages of diabetes drug Ozempic in the European Union that are expected to continue into the final quarter...
